Managing Director, Versant Venture Management, LLC

0001104659-18-003973.txt : 20180125 0001104659-18-003973.hdr.sgml : 20180125 20180125145754 ACCESSION NUMBER: 0001104659-18-003973 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20171231 FILED AS OF DATE: 20180125 DATE AS OF CHANGE: 20180125 EFFECTIVENESS DATE: 20180125 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Versant Venture Management, LLC CENTRAL INDEX KEY: 0001560009 IRS NUMBER: 954767945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16849 FILM NUMBER: 18548018 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001560009 XXXXXXXX 12-31-2017 12-31-2017 false Versant Venture Management, LLC

One Sansome Street, Suite 3630 San Francisco CA 94104

13F HOLDINGS REPORT 028-16849 N Robin L. Praeger Managing Director, Versant Venture Management, LLC 415-801-8100 /s/ Robin L. Praeger San Francisco CA 01-24-2018 0 7 95029118 false INFORMATION TABLE 2 a18-3794_1informationtable.xml INFORMATION TABLE Clovis Oncology, Inc. Common Stock 189464100 6926140 101855 SH OTR 0 101855 0 CymaBay Therapeutics, Inc. Common Stock 23257D103 9647127 1048601 SH OTR 0 1048601 0 Achaogen, Inc. Common Stock 004449104 13759572 1281152 SH OTR 0 1281152 0 Second Sight Medical Products, Inc. Common Stock 81362J100 8581582 4492975 SH OTR 0 4492975 0 Ocular Therapeutix, Inc. Common Stock 67576A100 9858459 2215384 SH OTR 0 2215384 0 Audentes Therapeutics, Inc. Common Stock 05070R104 37644219 1204615 SH OTR 0 1204615 0 ImmuneDesign Corp. Common Stock 45252L103 8612019 2208210 SH OTR 0 2208210 0